Balasa Dinverno & Foltz’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.06M | Buy |
53,033
+1,266
| +2% | +$125K | 0.32% | 34 |
|
|
2022
Q2 | $4.8M | Sell |
51,767
-5,372
| -9% | -$524K | 0.3% | 36 |
|
|
2022
Q1 | $5.78M | Buy |
57,139
+2,855
| +5% | +$300K | 0.39% | 28 |
|
|
2021
Q4 | $5.6M | Buy |
54,284
+1,785
| +3% | +$165K | 0.36% | 34 |
|
|
2021
Q3 | $4.46M | Buy |
52,499
+3,460
| +7% | +$290K | 0.31% | 34 |
|
|
2021
Q2 | $4.09M | Buy |
49,039
+1,240
| +3% | +$102K | 0.29% | 33 |
|
|
2021
Q1 | $3.6M | Buy |
47,799
+1,375
| +3% | +$100K | 0.29% | 34 |
|
|
2020
Q4 | $3.17M | Sell |
46,424
-11,098
| -19% | -$722K | 0.26% | 37 |
|
|
2020
Q3 | $3.36M | Buy |
57,522
+30,335
| +112% | +$1.89M | 0.32% | 32 |
|
|
2020
Q2 | $1.77M | Buy |
27,187
+9,906
| +57% | +$624K | 0.2% | 48 |
|
|
2020
Q1 | $1.02M | Buy |
17,281
+4,135
| +31% | +$276K | 0.13% | 82 |
|
|
2019
Q4 | $977K | Buy |
13,146
+5,636
| +75% | +$396K | 0.1% | 98 |
|
|
2019
Q3 | $474K | Buy |
7,510
+2,943
| +64% | +$174K | 0.05% | 156 |
|
|
2019
Q2 | $249K | Sell |
4,567
-1,062
| -19% | -$57.2K | 0.03% | 209 |
|
|
2019
Q1 | $304K | Sell |
5,629
-4,269
| -43% | -$263K | 0.04% | 185 |
|
|
2018
Q4 | $649K | Buy |
9,898
+2,307
| +30% | +$172K | 0.08% | 105 |
|
|
2018
Q3 | $598K | Buy |
7,591
+1,266
| +20% | +$90.5K | 0.07% | 118 |
|
|
2018
Q2 | $407K | Sell |
6,325
-1,000
| -14% | -$65.9K | 0.06% | 146 |
|
|
2018
Q1 | $456K | Buy |
7,325
+34
| +0.5% | +$2.44K | 0.07% | 127 |
|
|
2017
Q4 | $529K | Sell |
7,291
-517
| -7% | -$37.6K | 0.08% | 111 |
|
|
2017
Q3 | $635K | Buy |
7,808
+425
| +6% | +$33.6K | 0.1% | 90 |
|
|
2017
Q2 | $594K | Sell |
7,383
-131
| -2% | -$10.3K | 0.1% | 91 |
|
|
2017
Q1 | $590K | Buy |
7,514
+217
| +3% | +$17.3K | 0.1% | 84 |
|
|
2016
Q4 | $576K | Sell |
7,297
-43
| -0.6% | -$3.48K | 0.1% | 82 |
|
|
2016
Q3 | $653K | Sell |
7,340
-61
| -0.8% | -$5.76K | 0.12% | 71 |
|
|
2016
Q2 | $709K | Sell |
7,401
-165
| -2% | -$16.4K | 0.13% | 64 |
|
|
2016
Q1 | $785K | Sell |
7,566
-317
| -4% | -$30.8K | 0.14% | 53 |
|
|
2015
Q4 | $771K | Sell |
7,883
-357
| -4% | -$35K | 0.13% | 58 |
|
|
2015
Q3 | $795K | Buy |
8,240
+419
| +5% | +$44K | 0.14% | 55 |
|
|
2015
Q2 | $820K | Sell |
7,821
-5
| -0.1% | -$511 | 0.13% | 50 |
|
|
2015
Q1 | $808K | Buy |
7,826
+157
| +2% | +$15.9K | 0.12% | 54 |
|
|
2014
Q4 | $739K | Buy |
7,669
+243
| +3% | +$21.4K | 0.11% | 63 |
|
|
2014
Q3 | $591K | Sell |
7,426
-11
| -0.1% | -$867 | 0.09% | 75 |
|
|
2014
Q2 | $561K | Buy |
7,437
+172
| +2% | +$13K | 0.06% | 69 |
|
|
2014
Q1 | $544K | Buy |
7,265
+799
| +12% | +$56.4K | 0.07% | 69 |
|
|
2013
Q4 | $463K | Buy |
6,466
+63
| +1% | +$4.05K | 0.06% | 75 |
|
|
2013
Q3 | $363K | Buy |
6,403
+60
| +0.9% | +$3.58K | 0.06% | 83 |
|
|
2013
Q2 | $363K | Buy |
+6,343
| New | +$367K | 0.06% | 80 |
|
Other funds holding CVS
Balasa Dinverno & Foltz's CVS Position: Q3 2022 in Review
Balasa Dinverno & Foltz increased its CVS Health (CVS) stake by 2.4% in Q3 2022, buying an estimated $125K and bringing the position to 53,033 shares worth $5.06M. The position accounts for 0.32% of the portfolio, ranked #34.
Balasa Dinverno & Foltz first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $5.78M in Q1 2022. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- Balasa Dinverno & Foltz held 53,033 shares of CVS Health worth $5.06M as of Q3 2022.
- Balasa Dinverno & Foltz bought 1,266 CVS Health shares in Q3 2022, an estimated $125K.
- CVS Health made up 0.32% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #34 holding.
- Balasa Dinverno & Foltz first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- Balasa Dinverno & Foltz's CVS Health position peaked at $5.78M in Q1 2022.
- 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.